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DDT Risk Assessments
Two recent articles in EHP (1,2) and the
latest Agency for Toxic Substances and
Disease Registry toxicologic profile for
DDT (3) make repeated references to DDT
risks. These statements of risk, like so many
others, are one-sided and give no considera-
tion to colossal increases in diseases previ-
ously controlled with DDT. Behind disease
statistics are grievous human tragedies, as
with the case of a little girl who died of an
infection that could have been prevented if
her house had been sprayed with DDT.
She lived in a village in the Andes and
was 8 years old in 1998 when she died
of bartonellosis. Bartonellosis was previ-
ously controlled through malaria house-
spray programs, but without DDT, the dis-
ease returned.
One-sided and narrowly focused risk
assessments form the bedrock of anti-DDT
advocacy (4,5), but advocacy for global elim-
ination of DDT through United Nations
Environment Programme (UNEP) treaty
negotiations failed (6). Countries can con-
tinue using DDT for disease control, and
DDT is not listed for global elimination.
This outcome was possible only through
efforts of hundreds of scientists on behalf of
hundreds of millions of people at risk of ill-
ness and death from malaria (7).
Environmental activists who still want
DDT eliminated and who are surprised by
the lack of cost-effective alternatives should
understand that global vilification of DDT
eliminated almost all research on public
health insecticides. Lack of research sup-
port persists and contrasts sharply with the
richness of funds for research on adverse
health effects of DDT; 29 major projects
are presently funded by the National
Institutes of Health (National Institute of
Environmental Health Sciences, National
Cancer Institute, National Institute of
General Medical Sciences, and the
National Institute of Child Health and
Human Development) (3).
The evidence of DDT efficacy in con-
trolling diseases is irrefutable. In just 3
years, house spraying in Guyana reduced
maternal and infant mortalities by 56% and
39%, respectively, and reduced malaria
cases by 99% (8). Similar evidence from
other geographic areas persuaded delegates
to UNEP treaty negotiations that DDT is
still needed. Yet, and in spite of all contrary
evidence, the UN program to phase out
DDT is unabated (9,10). The current
“phase-out” program by the World Health
Organization’s Roll Back Malaria initiative
and the Global Environment Facility
(Washington, DC) includes no publicized
disease control performance standards and
does not include appropriate on-site studies
or tests to determine, under varying epi-
demiologic and environmental conditions,
that DDT alternatives will provide adequate
and sustained protection of rural popula-
tions. After years of successful efforts, the
modus operandi of DDT elimination
remains the same: apply political and eco-
nomic pressures, convince country politi-
cians that DDT is not needed, pass laws
banning its use, and let impoverished rural
populations quietly suffer spiraling increases
in disease rates (11,12). Even short-term
commitments of funds for purchasing the
more expensive and less effective DDT
alternatives are a continuation of past prac-
tices: in the end, disease rates will increase.
The Andean girl’s death is one of mil-
lions of preventable deaths that occurred as
national and international regulations,
trade barriers, international policies, and
UN resolutions were applied to stop public
health uses of DDT (13). With absolute
certainty, the best measures of success in the
anti-DDT campaign are increases in dis-
ease and death from malaria, leishmaniasis,
bartonellosis, dengue fever, and dengue
hemorrhagic fever. We can add to this list
the renewed threat that urban yellow fever
will once again ravage populations of the
Americas. Even this emerging threat is
linked to past failures to continue appropri-
ate public health uses of DDT. The Andean
girl’s unrecognized but precious stake in the
DDT issue was her life, now lost. How
many millions more must die because of
hypothetical risks from minute quantities of
DDT sprayed on internal house walls?
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DDT Risk Assessments:
Response
Donald Roberts contends that organiza-
tions such as the World Wildlife Fund
(WWF) failed in efforts to eliminate DDT
under the recently negotiated persistent
organic pollutants (POPs) treaty.
To the contrary, the WWF strongly
supports the treaty’s language on DDT.
Throughout the negotiations, the WWF
recognized that DDT should not be
banned immediately and that uncertainties
about the cost and effectiveness of alterna-
tives required flexibility in treaty language
(1,2). Reflecting this, the new treaty pro-
claims ultimate elimination of DDT as a
goal while establishing a mechanism for
reducing reliance on DDT and promoting
alternatives (3). As a result of the treaty,
new funds are being provided by the
Global Environment Facility to develop
malaria control programs that reduce use
of DDT.
Roberts has been an outspoken defender
of DDT. He has prolifically and passion-
ately downplayed the toxicologic risks of
DDT while emphasizing its effectiveness
for malaria control (4–6). He frequently
argues that external political pressures drive
poorer nations to abandon DDT, thereby
endangering millions of the world’s most
impoverished people. 
Malaria-endemic countries have had
ample scientific justification for seeking
alternatives. For example, in the mid-1990s,
Mexican public health researchers expressed
concern about high human exposures to
DDT as a result of malaria control opera-
tions (7,8). Mexico has since eliminated
DDT while successfully combating malaria.
South Africa also sought to reduce use of
DDT in the mid-1990s because of concern
about elevated levels in mothers’ milk (9).
One species of mosquito was resistant to
alternative sprays, so South Africa resumed
using DDT. South Africa concluded that
the hazards from malaria outweigh those
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Africa’s experience underscores the impor-
tance of the flexibility provided by the
POPs treaty.
Brazil and India offer important lessons
about limits to DDT’s effectiveness. During
the late 1980s and early 1990s, malaria rates
in Brazil went up even as spraying of houses
with DDT increased, but dropped after
Brazil shifted strategies (10). With assistance
from the World Bank, India is reducing its
reliance on DDT. The main rural malaria
vector (responsible for 65% of India’s
malaria) is resistant to DDT (11). Indian
researchers found elevated levels of DDT in
buffalo milk, soil, water, and human blood
where DDT had been sprayed to control
malaria (12,13).
The ATSDR’s 2000 update of its toxi-
cologic profile for DDT/DDE (14) reflects
major concerns raised by the WWF and
other environmental and public health
groups during the POPs negotiations. In
contrast to the previous profile published in
the early 1990s, the update contains a large
section, “Health Effects in Wildlife
Potentially Relevant to Human Health,”
reminding readers that animals are sentinels
for health effects in humans. A new section
captioned “Children’s Susceptibility” reiter-
ates a central message from the U.S.
National Academy of Sciences’ landmark
1993 report on pesticides in the diets of
infants and children (15): children are not
little adults, but may be uniquely suscepti-
ble and exposed to pesticides. 
The data in the toxicologic profile sup-
port the logic of the POPs treaty: DDT can
be valuable for controlling malaria, but it is
prudent to reduce human exposures.
Recent studies on humans, too late to be
included in the toxicologic profile, further
support such caution. For example,
Longnecker et al. (16) found that DDE
concentrations in mothers are associated
with increased risk of pre-term delivery and
lowered birth weight. 
Roberts takes EHP’s contributors to
task for their “one-sided” references to
DDT’s risks and their failures to account
for DDT’s benefits. Roberts’ encomium to
DDT is itself one-sided. Why expose
humans to hazards from DDT when less
risky strategies might be employed? The
POPs treaty encourages development of
alternatives and provides a new funding
mechanism to support malaria control.
Richard A. Liroff
Alternatives to DDT Project
World Wildlife Fund
Washington, D.C.
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Mercury and Autistic Gut
Disease
We are challenged to consider the possible
role of environmental toxins in autism and
other childhood behavioral disorders (1),
and creative research in this area surely is
warranted (2). Perhaps particular scrutiny
should be given to mercury and autism.
Many signs and symptoms of mercury
exposure correspond to autism (3), and
pink disease (acrodynia) from inorganic
mercurial teething powders and autism bear
strong behavioral resemblance. 
Gut disease with inflammation is
becoming increasingly evident in autism.
Enterocolitis and lymphonodular hyperpla-
sia are found in nearly 90% of regressed
autistic children (4). Widespread inflamma-
tory changes with poor intestinal digestive
enzyme activity (5), abnormal intestinal 
permeability (6), and malabsorption (7)
have been reported in various autistic sub-
groups. It would be logical to consider tox-
ins known to cause gut injury when we look
for causes of autism.
Inorganic mercurial compounds are
notorious for gut injury in humans. In ani-
mals, chronic low-nanomolar exposure
injures intestinal mucosa (8) and 30-min
micromolar exposure injures the colon (9).
Also, desposits of antibody in the intestine
have resulted from chronic exposure to
inorganic mercury (10). 
Although systemic passage may be poor,
inorganic mercury enjoys avid uptake by the
small and large intestines (11). Organic and
vapor forms are known to transit mem-
branes quickly and distribute throughout
the body, but their excretion is primarily
fecal and significantly inorganic, which may
affect intestinal residence.
Biliary mercury excretion, predomi-
nant in adults, is not achieved in suckling
animals and may not exist in infants (12).
Ligation of the bile duct of adult animals
results in retograde movement of systemic
mercury to the feces, emphasizing an
excretory role for the intestine (13). Poor
biliary excretion in infants might be
expected to increase intestinal exposure to
mercury. In suckling animals, two-thirds
of total ingested inorganic mercury is
recoverable after 6 days from gut tissue,
particularly the ileum (14).
Worrisome levels of inorganic mercury
exist in domestic water supplies (15) and in
industrial emissions and municipal sludge
widely used as fertilizer on crops (16). Up
to 40% of mercury emissions from hydro-
carbon combustion and 60% from inciner-
ators is in the inorganic form (17), and
mercurial “fall-out” may exceed 1 ppm in
soil (18). Individual inorganic mercury
ingestion can vary widely and may be
greater than expected (19).
Some specifics about autism should
heighten interest in mercury. A long clinical
tradition has evolved in the use of vitamin
B6, and its activating enzyme (B6-kinase) is
totally inhibited in the intestine at nanomo-
lar concentrations in vitro (20). Organic
forms of mercury such as methyl mercury
from fish and ethyl mercury as a vaccine
preservative (thimersol) may also inflict gut
injury. Methyl mercury in primates pro-
duces histologic abnormality of one intesti-
nal cell line: Paneth cells are enlarged and
packed with secretory granules (21), also
specifically reported in autistic children (5). 
Woody R. McGinnis
Tucson, Arizona 
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Corrections and Clarifications
Toussaint et al. discovered an error in a
spreadsheet formula that affected some of the
results in their paper [Chronic Toxicity of
Chloroform to Japanese Medaka Fish.
Environmental Health Perspectives
109:35–40 (2001)]. The intrahepatic level of
chloroform at the 0.151 mg/L aquaria con-
centration was erroneously reported at 33 and
133 mg chloroform/g fish liver; the correct
concentrations of chloroform in these two
fish livers were 0.8 and 3.3 mg chloroform/kg
fish liver. At the 1.463 mg/L aquaria chloro-
form concentration, the intrahepatic concen-
trations were incorrectly reported as 23, 26,
35, 41, 128, 144, 159, 194, and 219 mg/g
fish liver. The correct intrahepatic concentra-
tions for the 1.463 mg/L fish are 0.50, 0.58,
0.65, 1.03, 3.19, 3.59, 3.98, 4.84, and 5.48
mg chloroform/kg fish liver. Additionally, the
chloroform peak in Figure 3 was incorrectly
labeled; it should read 0.50 mg CHCl3/kg
fish liver (see correct figure below). 
The authors regret the error.
In the Editorial by Axelrod et al. [It’s Time
to Rethink Dose: The Case for Combining
Cancer and Birth and Developmental
Defects. Environ Health Perspect
109:A246–A249 (2001)], two references
were reversed in the “References and Notes.”
The correct references are as follows:
22. Staessen JA, Gasowski J, Wang JG, Thijs L, Hond ED,
Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, et al.
Renal function, cytogenetic measurements, and sexual
development in adolescents in relation to environmental
pollutants: a feasibility study of biomarkers. Lancet
357:1660–1669 (2001).
23. Sharpe RM, Skakkeback NE. Are oestrogens involved in
falling sperm counts and disorders of the male reproduc-
tive tract? Lancet 341:1392–1395 (2000).
In “Examination of the Melatonin
Hypothesis in Women Exposed at Night to
EMF or Bright Light” by Graham et al.
[Environ Health Perspect 109:501–507
(2001)], the keys in Figures 4 and 5 are
incorrect. The corrected figures are shown
below. EHP regrets the error.
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Figure 5. Mean (± SE) estradiol levels are plot-
ted from 2100 hr to 0700 hr for the luteal group
(n = 8) initially exposed for 4 hr to bright (5,200
lx) light or to dim (25 lx) light (study 3). Similar
data are presented for the follicular group (n =
8) exposed to the bright and dim light condi-
tions. Unlike the profound changes observed in
melatonin (Figure 4), no alterations in point-by-
point matching measures of estradiol were
found in either phase of the menstrual cycle. 
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Figure 4. Mean (± SE) melatonin levels are plot-
ted from 2100 hr to 0700 hr for eight women in
the follicular menstrual phase (days 3–8) initially
exposed for 4 hr to bright (5,200 lx) light or to
dim (25 lx) light (study 3). Similar data are shown
for eight women in the luteal phase (days 18–23)
exposed to the same bright and dim light condi-
tions. Bright light reduced the total amount of
melatonin secreted (p < 0.0001) and delayed
peak blood concentrations by 4 hr. 
80
70
60
50
40
30
20
10
0
M
e
l
a
t
o
n
i
n
 
(
p
g
/
m
L
)



 

 



 


  




 





 













Hour
2
4
0
0
0
1
0
0
0
2
0
0
0
3
0
0
0
4
0
0
0
5
0
0
0
6
0
0
0
7
0
0
2
3
0
0
2
2
0
0
2
1
0
0
5,200 lx, follicular
25 lx, follicular
5,200 lx, luteal
25 lx, luteal
Figure 3. Chromatogram of a fish liver sample
used to determine intrahepatic chloroform con-
centration in medaka fish exposed to 1.463 mg/L
chloroform for 9 months. Peaks include the
injection peak, two unknown peaks, and the
chloroform peak, respectively. Instrumental
detection limits of chloroform were 0.001 mg/L. 